Estimate Time5 min

Why markets may be stronger than they seem

Key takeaways

  • High valuations don't automatically mean the market is in a bubble.
  • Investor fear is unusually high. Historically, high levels of investor fear have often preceded periods of strong market returns.
  • Consumer pessimism is also unusually high, which has historically been a positive contrary indicator for consumer discretionary stocks.

2026 has already been eventful for investors. From new geopolitical tensions to renewed concerns over trade policy, there is no shortage of unsettling headlines.

However, as 2025 reminded investors, earnings can still grow and stocks can still rise even in a volatile news environment.

My research focuses on identifying patterns and probabilities in market history that can help inform the current outlook. Currently, my historical analysis suggests that stocks may continue to rise, and that the outlook could be particularly bright for technology, consumer discretionary, and health care stocks.

Here's more on 3 key themes for investors to consider now.

Read the full report

Get Fidelity's complete Q1 2026 Quarterly Sector and Investment Research Update, from the desk of Director of Quantitative Market Strategy Denise Chisholm.

Download the full report (PDF).

1. Some investors fear a bubble—but the data doesn’t support it

All historical market bubbles have been marked by high valuations—but not all periods with high valuations have been bubbles. I think we’re in the latter scenario.

Some investors highlight the S&P 500® Index’s high cyclically adjusted price-to-earnings (CAPE) ratio, a metric that divides current stock prices by the last 10 years’ inflation-adjusted earnings. They point to historical data showing that, on average, high CAPE ratios have been followed by weak 10-year returns. And they note that the market’s current CAPE ratio of 40 is the highest it’s ever been outside of the dot-com bubble of the late 1990s.

All that is true. But my analysis finds that the most important factor affecting 10-year returns hasn’t been valuations—it’s been whether the period ended in a crisis. Since 1932, almost all the 10-year periods with high starting CAPE and weak returns concluded during either World War II, the inflationary recessions of the early 1980s, or the 2008 financial crisis. When 10-year periods began with high CAPE ratios and did not end during one of these crises, they delivered 10% average annualized returns—better than the market’s historical average.

The CAPE ratio at the start of each period did have an impact. Among 10-year periods that didn’t end in a crisis, those with low starting CAPE ratios had higher average returns. But whether a period ended in crisis mattered more. For example, 10-year periods that started with low CAPE but ended during a crisis had annualized returns of just 5%, on average.

The takeaway: The historical connection between high valuations, as measured by the CAPE ratio, and weak long-term returns may not be as strong as it appears.

Corporate overinvestment has historically been another sign of a bubble. Some investors worry that’s happening today, given huge companies’ investments in artificial intelligence (AI). But the data suggests otherwise. As of last year, S&P 500 companies were generally spending about 86% of their cash flow on capital expenditures (capex), on average. That’s actually significantly lower than the average pace of capex spending since 1962 (128% of cash flow). It’s also far lower than the levels seen during the dot-com bubble (when many companies were spending around 150% to 400% of cash flow on capex).

In the tech sector, annual cash flow exceeds capex by a wide margin, and it has since 2002. And the sector’s results are underpinned by powerful fundamentals: Technology company earnings have grown faster than the rest of the market’s since 2022.

2. Contrarian signals may point to further market strength

Several indicators that could seem negative may actually signal potential opportunity in the stock market. One is the fact that stock investors look much more fearful than bond investors.

I like to gauge relative fear in the stock and bond markets using the ratio of the CBOE Volatility Index (VIX) to high-yield credit spreads (the VIX index is a proxy for the level of volatility in the stock market; credit spreads represent the additional yield bond investors demand in exchange for taking on credit risk). A higher ratio implies that stock investors are more fearful than bond investors. A higher ratio has also historically tended to precede stronger stock market returns.

Recently, the ratio climbed to the top 3% of its range since 1990. Historically, when this ratio has reached the top 3% of its range, the stock market has gone on to return 24% over the next 12 months, on average. (This is one reason bonds have a reputation as the "smarter” market.)

Investor sentiment is another contrarian signal, and it’s telling a similar story. It recently fell to the bottom 10% of its range since the 1980s. While such extreme pessimism may sound ominous, it has tended to precede strong gains. In fact, 6-month periods that began with bottom-decile sentiment have produced average returns of about 8%, looking at market data since 1987.

If these signals seem counterintuitive, then just remember: The more worried investors are, the easier it is for things to turn out better than expected.

3. Surprising signals for consumer discretionary and health care

I’m also watching several sector-specific contrarian indicators. Take consumer sentiment, which has been hovering near all-time lows. It seems natural to assume such negativity spells bad news for the consumer discretionary sector: If people feel bad about their finances and the overall economy, you’d expect them to pull back on nonessential purchases.

Yet history tells a different story. Since 1970, when sentiment was in the lowest 5% of its historical range, consumer discretionary stocks outperformed the market by an average of 7 percentage points over the next 12 months. The likely reason: Pessimism was already priced into the market, leaving room for upside if conditions improved.

Health care is another sector that has been flashing a contrarian signal. In recent years, the sector has faced weak earnings and declining valuations. Counterintuitively, that backdrop has been a good setup for subsequent outperformance in the past. Periods like these have tended to produce both higher odds of market-beating returns over the next 12 months and relatively strong risk-adjusted returns.

That said, while I believe the health care sector’s near-term prognosis is good, I remain cautious about longer-term prospects due to declines in the sector's average margins and valuations, which have been playing out over the long term. 

How to search for investing ideas

Based on this analysis and other research, I believe that today’s anxieties could set the stage for future upside potential. I expect leadership from technology and consumer discretionary stocks, and I have upgraded health care in the near term but recommend caution with the sector longer term.

Investors interested in matching investing ideas to these themes can search for stocks using the Fidelity Stock ScreenerLog In Required. Or, to search for mutual funds or ETFs that focus on these themes, investors can use the Fidelity Mutual Funds Research tool or ETF ScreenerLog In Required.

Denise Chisholm, Sector Strategist, Fidelity
Denise Chisholm, Director of Quantitative Market Strategy

Denise Chisholm is director of quantitative market strategy in the Quantitative Research and Investments (QRI) division at Fidelity Investments. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing, and other financial products and services to institutions, financial intermediaries, and individuals.

In this role, Ms. Chisholm is focused on historical analysis, its application in diversified portfolio strategies, and ways to combine investment building blocks, such as factors, sectors, and themes. In addition to her research responsibilities, Ms. Chisholm is a popular contributor at various Fidelity client forums, is a LinkedIn 2020 Top Voice, and frequently appears in the media.

Prior to assuming her current position, Ms. Chisholm was a sector strategist focused on sector strategy research, its application in diversified portfolio strategies, and ways to combine sector-based investment vehicles. Ms. Chisholm also held multiple roles within Fidelity, including research analyst on the mega cap research team, research analyst on the international team, and sector specialist.

Previously, Ms. Chisholm performed dual roles as an equity research analyst and director of Independent Research at Ameriprise Financial. In this capacity, she focused on the integration of differentiated research platforms and methodologies. Before joining Fidelity in 1999, Ms. Chisholm served as a cost-of-living consultant for ARINC and as a Department of Defense statistical consultant at MCR Federal. She has been in the financial industry since 1999.

Ms. Chisholm earned her bachelor of arts degree in economics from Boston University.

Put your investing ideas to work

Get industry-leading research, guidance, tools, and pricing.

More to explore

References to specific securities or investment themes are for illustrative purposes only and should not be construed as recommendations or investment advice. This information must not be relied upon in making any investment decision. Fidelity cannot be held responsible for any type of loss incurred by applying any of the information presented. These views must not be relied upon as an indication of trading intent of any Fidelity fund or Fidelity advisor. Investment decisions should be based on an individual's own goals, time horizon, and tolerance for risk. This piece may contain assumptions that are "forward-looking statements," which are based on certain assumptions of future events. Actual events are difficult to predict and may differ from those assumed. There can be no assurance that forward-looking statements will materialize or that actual returns or results will not be materially different from those described here.

Past performance is no guarantee of future results.

Investing involves risk, including risk of loss.

Views expressed are as of the date indicated, based on the information available at that time, and may change based on market or other conditions. Unless otherwise noted, the opinions provided are those of the speaker or author and not necessarily those of Fidelity Investments or its affiliates. Fidelity does not assume any duty to update any of the information.

Stock markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments. Investing in stock involves risks, including the loss of principal.

In general, the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities). Fixed income securities also carry inflation risk, liquidity risk, call risk and credit and default risks for both issuers and counterparties. Lower-quality fixed income securities involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Foreign investments involve greater risks than U.S. investments, and can decline significantly in response to adverse issuer, political, regulatory, market, and economic risks. Any fixed-income security sold or redeemed prior to maturity may be subject to loss.

The technology industries can be significantly affected by obsolescence of existing technology, short product cycles, falling prices and profits, competition from new market entrants, and general economic condition.

The consumer discretionary industries can be significantly affected by the performance of the overall economy, interest rates, competition, consumer confidence and spending, and changes in demographics and consumer tastes.

The health care industries are subject to government regulation and reimbursement rates, as well as government approval of products and services, which could have a significant effect on price and availability, and can be significantly affected by rapid obsolescence and patent expirations.

​As with all your investments through Fidelity, and in connection with your evaluation of the security, you must make your own determination whether an investment in any particular security or securities is consistent with your investment objectives, risk tolerance, and financial situation. Fidelity is not recommending or endorsing this investment by making it available to its customers.

The S&P 500® Index is a market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent US equity performance. The CBOE Volatility Index (VIX) measures the market's expectation of 30-day volatility for the S&P 500. It is not possible to invest directly in an index.

Fidelity Brokerage Services LLC, Member NYSE, SIPC, 900 Salem Street, Smithfield, RI 02917

1245510.1.0